Medical Devices News

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in Citi’s Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ullem, chief financial officer, is scheduled to present at 10:15 a.m. ET. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day. About Edwards Lifesciences Edwards L...

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a collaboration with Median Technologies (EPA: ALMDT) to bring Median’s proprietary eyonis® LCS to the Tempus Pixel platform. This collaboration empowers clinical workflows with a powerful tool to support informed diagnostic and disease management decisions. According to a study by the American Cancer Society, only about 20% of eligible individu...

SOPHIA ANTIPOLIS, France & CHICAGO--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), developer of eyonis®, a suite of artificial intelligence (AI) powered Software as a Medical Device (SaMD) for early cancer diagnosis, and a provider of AI-enhanced and central imaging services for oncology drug developers, today announced its non-exclusive distribution agreement with Tempus AI, Inc. (NASDAQ: TEM) a technology company leading the adoption of...

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release fourth quarter and full year 2025 financial results for the period ended January 3, 2026, after the market closes on Thursday, February 26, 2026. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Katie Szyman, Chief Executive Officer, and Micah Young, Chief Financial Officer. To register for the conference call or the webcast, please use the link below. Upon registering, e...

EL SEGUNDO, Calif. & ANDOVER, Mass.--(BUSINESS WIRE)--KARL STORZ North America, a global leader in advanced visualization and Operating Room (OR) integration, has teamed up with Smith+Nephew, a leading medical technology company recognized for its strength in sports medicine and orthopedics, to support hospitals and ambulatory surgery centers (ASCs) with complementary visualization solutions. The companies will collaborate to align Smith+Nephew’s clinically respected sports medicine portfolio w...

CANTON, Mass.--(BUSINESS WIRE)--MEDITECH to showcase how the intelligent Expanse EHR empowers providers and improves outcomes at HIMSS26....

NATICK, Mass.--(BUSINESS WIRE)--AutoIVF, a fertility technology company developing automated solutions for reproductive medicine, today announced the publication of a peer-reviewed clinical study in Nature Medicine describing the recovery of additional oocytes from discarded follicular fluid following standard clinical screening using the company’s automated egg-recovery technology, OvaReady™. The study evaluated follicular fluid samples from 582 patients across four accredited in vitro fertili...

PERTH, Australia--(BUSINESS WIRE)--OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™. The Funding round included a cornerstone investment from Brandon Capital Partners’ BB6 Fund; significant investment from Morgans; Radar Ventures; Australian and international family offices and The Table Club network. Elora™ provides...